From: Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
Characteristic | Total (N = 600) | IPF (N = 279) | Non-IPF (N = 321) |
---|---|---|---|
Median age (range), years | |||
Male | 69 (16–92) | 70 (29–92) | 66 (16–83) |
Female | 62 (21–94) | 64 (21–84) | 61 (30–94) |
Gender, n (%) | |||
Male | 300 (50.0) | 164 (58.8) | 136 (42.4) |
Female | 300 (50.0) | 115 (41.2) | 185 (57.6) |
Diagnosis, n (%) | |||
Idiopathic pulmonary fibrosis | 279 (46.5) | 279 (100.0) | 0 (0.0) |
Interstitial lung disease * | 195 (32.5) | 0 (0.0) | 195 (60.7) |
Non-specific interstitial pneumonia | 93 (15.5) | 0 (0.0) | 93 (29.0) |
Hypersensitivity pneumonitis | 27 (4.5) | 0 (0.0) | 27 (8.4) |
Sarcoidosis | 6 (1.0) | 0 (0.0) | 6 (1.9) |
Time since diagnosis, n (%) | |||
≤ 6 months | 32 (5.3) | 18 (6.5) | 14 (4.4) |
> 6 months to 1 year | 59 (9.8) | 33 (11.8) | 26 (8.1) |
> 1 to 2 years | 126 (21.0) | 61 (21.9) | 65 (20.2) |
> 2 to 5 years | 204 (34.0) | 93 (33.3) | 111 (34.6) |
> 5 to 10 years | 127 (21.2) | 57 (20.4) | 70 (21.8) |
> 10 years | 52 (8.6) | 17 (6.1) | 35 (10.9) |
Comorbid conditions, n (%) | |||
Gastroesophageal reflux disease | 260 (43.3) | 115 (41.2) | 145 (45.2) |
Sleep apnea | 134 (22.3) | 68 (24.4) | 66 (20.6) |
Allergy | 124 (20.7) | 52 (18.6) | 72 (22.4) |
Cardiovascular disease | 122 (20.3) | 59 (21.1) | 63 (19.6) |
Pulmonary hypertension | 103 (17.2) | 37 (13.3) | 66 (20.6) |
Other pulmonary conditions † | 356 (59.3) | 156 (55.9) | 200 (62.3) |
Family history of ILD, n (%) | |||
Yes | 102 (17.0) | 54 (19.4) | 48 (15.0) |
No | 498 (83.0) | 225 (80.6) | 273 (85.0) |